Tauopathies, such as Alzheimer’s disease (AD), frontotemporal dementia with parkinsonism, and progressive supranuclear palsy, are an increasingly prevalent class of neurodegenerative diseases characterized, in part, by hyperphosphorylation and aggregation of the microtubule-associated binding protein tau [1,2]. This evidence concerns the gene MAPT and Classical progressive supranuclear palsy.